Generic drugs account for more than 90% of prescriptions filled in the United States. The Food and Drug Administration insists that they “have the same high quality, strength, purity and stability as ...

Generic drugs account for more than 90 percent of prescriptions filled in the United States. The FDA insists that they “have the same high quality, strength, purity and stability as brand-name drugs.” ...

If you've ever admired the vintage-inspired look of mercury glass decor, you'll be surprised by how easy it is to recreate at home. This DIY mercury glass pumpkin craft delivers the same reflective, ...

The most common prescription drugs you pick up at the pharmacy counter or fill via mail order will likely get more expensive under President Donald Trump's plan to assess a 100% tariff on imported ...

Imported generic drugs will face a 100 percent tariff beginning in August 2028 unless manufacturers move production to the U.S., President Trump said in a social media post Tuesday. Trump wrote on ...

Trump plans tariffs of up to 200% on imported generic drugs after a two-year grace period aimed at encouraging U.S. manufacturing. But thin profit margins make tariffs harder to absorb than for ...

President Donald Trump on Tuesday announced a plan to impose a 100 percent tariff on generic drugs starting in August 2028 as part of a bid to push pharmaceutical production back to the United States.

The administration has repeatedly said it will impose steep pharmaceutical tariffs but has not followed through on them. By Rebecca Robbins President Trump said on Tuesday evening that he planned to ...

BOUNTIFUL — As a child, Jodie McDougall remembers being fascinated by glass paperweights, wondering how a picture got inside the glass bubble. "It was just one of those obscure things that I fell in ...

The Hikma Court correctly held that a generic manufacturer should not be liable for induced patent infringement if it carves patented uses out of its label. FDA can navigate Hikma’s aftermath without ...

Share on Pinterest Federal regulators have agreed to review a Swiss pharmaceutical company’s applications for two cheaper generic versions of Zepbound and Mounjaro. MK Photo/Alamy Stock Photo Federal ...

Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Carley ...